Safety and protection of intramuscular rabies vaccine.
Phase 4
- Conditions
- Health Condition 1: null- Dog bites
- Registration Number
- CTRI/2014/08/004875
- Lead Sponsor
- KIMS Hpspital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 70
Inclusion Criteria
Healthy subjects with Category III exposures.
If female, not pregnant or lactating at the time of enrolment and not planning pregnancy during the entire study period of 6 months.
Previously unvaccinated/unexposed person.
Willing to sign Informed consent to take 4 doses of IM vaccination (days 0, 3, 7 and 14), even when the dog is healthy and alive after 10 days.
Subjects available for minimum of 6 months follow-up.
Subjects willing to give blood samples on 4 recommended days i.e., on days 0, 14, 90 and 180.
Exclusion Criteria
Re exposure cases.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method